IMNM logo

Immunome, Inc. (IMNM) Cash From Investing

Annual CFI:

-$85.06M-$54.58M(-179.04%)
December 31, 2024

Summary

  • As of today, IMNM annual cash from investing is -$85.06 million, with the most recent change of -$54.58 million (-179.04%) on December 31, 2024.
  • During the last 3 years, IMNM annual cash from investing has fallen by -$84.98 million (-107574.68%).
  • IMNM annual cash from investing is now -107574.68% below its all-time high of -$79.00 thousand, reached on December 31, 2021.

Performance

IMNM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMNMcash flow metrics

Quarterly CFI:

-$64.17M-$69.26M(-1360.97%)
June 30, 2025

Summary

  • As of today, IMNM quarterly cash from investing is -$64.17 million, with the most recent change of -$69.26 million (-1360.97%) on June 30, 2025.
  • Over the past year, IMNM quarterly cash from investing has increased by +$17.52 million (+21.44%).
  • IMNM quarterly cash from investing is now -366.29% below its all-time high of $24.10 million, reached on September 30, 2024.

Performance

IMNM Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMNMcash flow metrics

TTM CFI:

-$25.23M+$17.52M(+40.98%)
June 30, 2025

Summary

  • As of today, IMNM TTM cash from investing is -$25.23 million, with the most recent change of +$17.52 million (+40.98%) on June 30, 2025.
  • Over the past year, IMNM TTM cash from investing has increased by +$123.73 million (+83.06%).
  • IMNM TTM cash from investing is now -46614.81% below its all-time high of -$54.00 thousand, reached on March 31, 2022.

Performance

IMNM TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMNMcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

IMNM Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-179.0%+21.4%+83.1%
3Y3 Years-10000.0%-10000.0%-10000.0%
5Y5 Years-10000.0%--

IMNM Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year>-9999.0%at low-366.3%+21.4%>-9999.0%+83.1%
5Y5-Year>-9999.0%at low-366.3%+21.4%>-9999.0%+83.1%
All-TimeAll-Time>-9999.0%at low-366.3%+21.4%>-9999.0%+83.1%

IMNM Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$64.17M(-1361.0%)
-$25.23M(+41.0%)
Mar 2025
-
$5.09M(-47.8%)
-$42.74M(+49.8%)
Dec 2024
-$85.06M(-179.0%)
$9.76M(-59.5%)
-$85.06M(+31.9%)
Sep 2024
-
$24.10M(+129.5%)
-$124.82M(+16.2%)
Jun 2024
-
-$81.69M(-119.4%)
-$148.96M(-120.3%)
Mar 2024
-
-$37.23M(-24.1%)
-$67.61M(-121.8%)
Dec 2023
-$30.48M(>-9900.0%)
-$30.00M(>-9900.0%)
-$30.48M(-5402.5%)
Sep 2023
-
-$36.00K(+89.4%)
-$554.00K(-6.9%)
Jun 2023
-
-$340.00K(-220.8%)
-$518.00K(-48.9%)
Mar 2023
-
-$106.00K(-47.2%)
-$348.00K(-40.3%)
Dec 2022
-$248.00K
-$72.00K(>-9900.0%)
-$248.00K(-30.5%)
DateAnnualQuarterlyTTM
Sep 2022
-
$0.00(+100.0%)
-$190.00K(+12.0%)
Jun 2022
-
-$170.00K(-2733.3%)
-$216.00K(-300.0%)
Mar 2022
-
-$6000.00(+57.1%)
-$54.00K(+31.6%)
Dec 2021
-$79.00K(+86.5%)
-$14.00K(+46.2%)
-$79.00K(+28.8%)
Sep 2021
-
-$26.00K(-225.0%)
-$111.00K(-30.6%)
Jun 2021
-
-$8000.00(+74.2%)
-$85.00K(-10.4%)
Mar 2021
-
-$31.00K(+32.6%)
-$77.00K(+23.8%)
Dec 2020
-$586.00K(-151.5%)
-$46.00K(+16.4%)
-$101.00K(-83.6%)
Mar 2020
-
-$55.00K
-$55.00K
Dec 2019
-$233.00K(-2.2%)
-
-
Dec 2018
-$228.00K
-
-

FAQ

  • What is Immunome, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Immunome, Inc.?
  • What is Immunome, Inc. annual cash from investing year-on-year change?
  • What is Immunome, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Immunome, Inc.?
  • What is Immunome, Inc. quarterly cash from investing year-on-year change?
  • What is Immunome, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Immunome, Inc.?
  • What is Immunome, Inc. TTM cash from investing year-on-year change?

What is Immunome, Inc. annual cash from investing?

The current annual cash from investing of IMNM is -$85.06M

What is the all-time high annual cash from investing for Immunome, Inc.?

Immunome, Inc. all-time high annual cash from investing is -$79.00K

What is Immunome, Inc. annual cash from investing year-on-year change?

Over the past year, IMNM annual cash from investing has changed by -$54.58M (-179.04%)

What is Immunome, Inc. quarterly cash from investing?

The current quarterly cash from investing of IMNM is -$64.17M

What is the all-time high quarterly cash from investing for Immunome, Inc.?

Immunome, Inc. all-time high quarterly cash from investing is $24.10M

What is Immunome, Inc. quarterly cash from investing year-on-year change?

Over the past year, IMNM quarterly cash from investing has changed by +$17.52M (+21.44%)

What is Immunome, Inc. TTM cash from investing?

The current TTM cash from investing of IMNM is -$25.23M

What is the all-time high TTM cash from investing for Immunome, Inc.?

Immunome, Inc. all-time high TTM cash from investing is -$54.00K

What is Immunome, Inc. TTM cash from investing year-on-year change?

Over the past year, IMNM TTM cash from investing has changed by +$123.73M (+83.06%)
On this page